Teachers Advisors’s Cytokinetics CYTK Stock Holding History

Teachers Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$761K	Hold	94,046	–	–	﹤0.01%	2399
2018 Q4	$594K	Hold	94,046	–	–	﹤0.01%	2434
2018 Q3	$926K	Buy	94,046 +10,081	+12%	+$80.9K	﹤0.01%	2348
2018 Q2	$697K	Buy	83,965 +7,346	+10%	+$61.1K	﹤0.01%	2509
2018 Q1	$552K	Hold	76,619	–	–	﹤0.01%	2489
2017 Q4	$624K	Buy	76,619 +2,344	+3%	+$26.6K	﹤0.01%	2467
2017 Q3	$1.08M	Hold	74,275	–	–	﹤0.01%	2191
2017 Q2	$899K	Buy	74,275 +13,949	+23%	+$194K	﹤0.01%	2297
2017 Q1	$775K	Buy	60,326 +7,048	+13%	+$82.4K	﹤0.01%	2315
2016 Q4	$647K	Buy	53,278 +2,025	+4%	+$21.5K	﹤0.01%	2404
2016 Q3	$471K	Hold	51,253	–	–	﹤0.01%	2495
2016 Q2	$486K	Hold	51,253	–	–	﹤0.01%	2425
2016 Q1	$361K	Sell	51,253 -549,987	-91%	-$4.02M	﹤0.01%	2518
2015 Q4	$6.29M	Buy	601,240 +37,555	+7%	+$368K	0.01%	1065
2015 Q3	$3.77M	Buy	563,685 +760	+0.1%	+$5.19K	0.01%	1224
2015 Q2	$3.78M	Buy	562,925 +176	+0%	+$1.15K	0.01%	1284
2015 Q1	$3.81M	Buy	562,749 +82,594	+17%	+$617K	0.01%	1278
2014 Q4	$3.85M	Buy	480,155 +35,206	+8%	+$151K	0.01%	1247
2014 Q3	$1.57M	Hold	444,949	–	–	﹤0.01%	1757
2014 Q2	$2.13M	Buy	444,949 +41,710	+10%	+$255K	﹤0.01%	1579
2014 Q1	$3.83M	Buy	403,239 +363,040	+903%	+$3.28M	0.01%	1216
2013 Q4	$261K	Buy	40,199 +5,650	+16%	+$37.1K	﹤0.01%	2730
2013 Q3	$262K	Buy	34,549 +1,822	+6%	+$19.5K	﹤0.01%	2687
2013 Q2	$379K	Buy	+32,727	New	+$258K	﹤0.01%	2386

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Teachers Advisors's CYTK Position: Q1 2019 in Review

Teachers Advisors held its Cytokinetics (CYTK) position steady in Q1 2019 at 94,046 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #2399.

Teachers Advisors first reported a position in CYTK in Q2 2013 and has held it in 24 quarters since. The position peaked at $6.29M in Q4 2015. 138 funds tracked by Wall St. Rank hold CYTK as of Q1 2019.

Teachers Advisors held 94,046 shares of Cytokinetics worth $761K as of Q1 2019.
Teachers Advisors left its Cytokinetics share count unchanged in Q1 2019.
Cytokinetics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2399 holding.
Teachers Advisors first reported a position in Cytokinetics in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's Cytokinetics position peaked at $6.29M in Q4 2015.
138 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.